{"id":"CHEMBL1084430","canonicalSmiles":"CO[C@@H]1[C@H](OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)C[C@@H]2O)[C@@H](CO)O[C@H]1n1ccc(=O)[nH]c1=O","inchiKey":"LYMICVBGNUEHGE-FUQPUAIBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INARIGIVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Inarigivir","ORI-9020","SB-40"],"crossReferences":{"drugbank":["DB15062"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1096979","canonicalSmiles":"NC(CO)C(=O)NNCc1ccc(O)c(O)c1O","inchiKey":"BNQDCRGUHNALGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENSERAZIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Benserazide","Benserazide hydrochloride","RO 4-4602","RO-4-4602"],"crossReferences":{"PubChem":["174006784","90341370"],"Wikipedia":["Benserazide"],"drugbank":["DB12783"],"chEBI":["64187"]},"childChemblIds":["CHEMBL1255778"],"count":2,"linkedTargets":{"rows":["ENSG00000132437"],"count":1},"linkedDiseases":{"rows":["EFO_0002508","EFO_0004270"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL110674","canonicalSmiles":"CC[C@H](C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCc1ccc(OC)c(OC)c1)c1cccc(OCC(=O)O)c1)c1cc(OC)c(OC)c(OC)c1","inchiKey":"XCCRAOPQCACRFC-OIFRRMEBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL110674","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01723"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL116","canonicalSmiles":"CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1","inchiKey":"YMARZQAQMVYCKC-OEMFJLHTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMPRENAVIR","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Agenerase"],"synonyms":["141 W94","141W94","Agenerase","Amprenavir","J05AE05","KVX-478","VX-478"],"crossReferences":{"Wikipedia":["Amprenavir"],"drugbank":["DB00701"],"chEBI":["40050"]},"count":3,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for viral disease and has 2 investigational indications."}
{"id":"CHEMBL1160253","canonicalSmiles":"CCC(=O)O.O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1","inchiKey":"OWKDVFWTVSYAHW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1160253","maximumClinicalTrialPhase":0,"parentId":"CHEMBL54","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1160756","canonicalSmiles":"CC(=O)N[C@@H](Cc1ccc(C(F)(F)P(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O","inchiKey":"LVZDQVATAQEMCX-NSOVKSMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1160756","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03591"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200379","canonicalSmiles":"Cl.Nc1cc(Cl)c(N=C2NCCN2)c(Cl)c1","inchiKey":"OTQYGBJVDRBCHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APRACLONIDINE HYDROCHLORIDE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL647","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Apraclonidine hydrochloride","Iopidine"],"synonyms":["AL-02145","AL02145","Aplonidine hydrochloride","Apraclonidine hydrochloride"],"crossReferences":{"DailyMed":["apraclonidine%20hydrochloride"],"PubChem":["144204758","50105753"],"chEBI":["2789"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987."}
{"id":"CHEMBL1200627","canonicalSmiles":"O=C1CCO1","inchiKey":"VEZXCJBBBCKRPI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPIOLACTONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betaprone"],"synonyms":["Propiolactone"],"crossReferences":{"PubChem":["144204577","17389751"],"Wikipedia":["Alpha-Propiolactone","Beta-Propiolactone"],"drugbank":["DB09348"],"chEBI":["49073"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1200692","canonicalSmiles":"CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1","inchiKey":"UQGKUQLKSCSZGY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OLMESARTAN MEDOXOMIL","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benicar","Olmesartan medoxomil","Olmetec"],"synonyms":["CS-866","Olmesartan medoxomil"],"crossReferences":{"DailyMed":["olmesartan%20medoxomil"],"PubChem":["144204998","26748978"]},"count":8,"approvedIndications":["EFO_0000319","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["EFO_0003914","EFO_0003086","MONDO_0021661","HP_0000093","EFO_0000401","EFO_0003144","EFO_1002032","EFO_0000319","MONDO_0002462","EFO_0000537"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for cardiovascular disease and hypertension and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200792","canonicalSmiles":"Cl.OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1","inchiKey":"CUXQPMGPJPHNFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUPHENAZINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL726","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Fluphenazine HCl"],"synonyms":[],"crossReferences":{"PubChem":["50125607","50125608","56422208","855962"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200851","canonicalSmiles":"C[N+]1(C)[C@H]2CC[C@@H]1C[C@H](OC(=O)C(O)c1ccccc1)C2.[Br-]","inchiKey":"FUFVKLQESJNNAN-RIMUKSHESA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"HOMATROPINE METHYLBROMIDE","yearOfFirstApproval":1943,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201235","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Equipin","Homapin","Homapin-10","Homapin-5"],"synonyms":["Homatropine methylbromide"],"crossReferences":{"DailyMed":["homatropine%20methylbromide"],"Wikipedia":["Methylhomatropine"]},"count":1,"approvedIndications":["EFO_0010282"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1943 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL1200989","canonicalSmiles":"CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@H]2[C@H]3[C@H]([C@@H](O)C[C@@]21C)[C@@]1(C)C=CC(=O)C=C1C[C@H]3Cl","inchiKey":"DJHCCTTVDRAMEH-DUUJBDRPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALCLOMETASONE DIPROPIONATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aclovate","Alclometasone dipropionate","Modrasone"],"synonyms":["Alclometasone","Alclometasone 17,21-dipropionate","Alclometasone dipropionate","SCH 22219","SCH-22219"],"crossReferences":{"DailyMed":["alclometasone%20dipropionate"],"PubChem":["144204277"],"chEBI":["31184"]},"count":2,"approvedIndications":["EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0005752","EFO_0003060"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for eye inflammation and has 1 investigational indication."}
{"id":"CHEMBL1200997","canonicalSmiles":"CS(=O)(=O)O.O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1","inchiKey":"LOQSYPGSAZUDJZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZIPRASIDONE MESYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL708","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-88059-27"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201203","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C[C@H](OC(c1ccccc1)c1ccccc1)C2","inchiKey":"GIJXKZJWITVLHI-PMOLBWCYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZTROPINE","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Benzatropine","Benztropine","NK-02"],"crossReferences":{"DailyMed":["benztropine%20mesylate"],"PubChem":["144204856","144205248","29215426"],"Wikipedia":["Benzatropine"],"drugbank":["DB00245"],"chEBI":["3048"]},"childChemblIds":["CHEMBL1200383"],"count":4,"approvedIndications":["EFO_0002508"],"linkedTargets":{"rows":["ENSG00000168539"],"count":1},"linkedDiseases":{"rows":["EFO_0002610","EFO_0002508","HP_0003418","EFO_0005279","EFO_0009387","EFO_0000692","HP_0011868","HP_0000713"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1954 and is indicated for parkinson's disease and has 3 investigational indications."}
{"id":"CHEMBL1201256","canonicalSmiles":"COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC","inchiKey":"FEZBIKUBAYAZIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETHOBENZAMIDE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Trimethobenzamide"],"crossReferences":{"DailyMed":["trimethobenzamide%20hydrochloride"],"PubChem":["11112414"],"Wikipedia":["Trimethobenzamide"],"drugbank":["DB00662"],"chEBI":["27796"]},"childChemblIds":["CHEMBL1200887"],"count":1,"approvedIndications":["EFO_0003785"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974 and is indicated for allergy."}
{"id":"CHEMBL1201572","drugType":"Protein","blackBoxWarning":true,"name":"ETANERCEPT","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benepali","Enbrel"],"synonyms":["Etanercept","GP-2015","GP2015","GP2015C","HD203","L04ab01","LBEC0101","RHU TNFR:FC","RHU-TNFR:FC","TNFR-IMMUNOADHESIN"],"crossReferences":{"DailyMed":["etanercept"],"DrugCentral":["4978"],"Wikipedia":["Etanercept"]},"count":51,"approvedIndications":["EFO_0000685","EFO_0003898","EFO_0003778","EFO_0000676","EFO_0000540","EFO_0002609"],"linkedTargets":{"rows":["ENSG00000232810"],"count":1},"linkedDiseases":{"rows":["EFO_1000710","EFO_0000249","EFO_0004274","MONDO_0002959","EFO_0007323","EFO_0000540","HP_0011868","EFO_0008997","EFO_0000565","EFO_0003884","EFO_0000676","EFO_0004208","EFO_0004276","EFO_0004719","EFO_0000198","MONDO_0013730","HP_0000360","EFO_0005761","EFO_0002687","HP_0002039","MONDO_0008315","EFO_0009448","MP_0001845","EFO_0007430","EFO_0000398","EFO_0009688","EFO_0000270","EFO_0001359","HP_0004326","EFO_0000341","Orphanet_314701","EFO_0000699","Orphanet_84","EFO_1001494","EFO_0003778","EFO_0004246","EFO_0008518","EFO_0005531","EFO_0005279","EFO_1000726","EFO_0000616","EFO_0000685","EFO_0003898","MONDO_0019558","EFO_0004599","EFO_0002609","EFO_0003106","EFO_0000195","EFO_0003834","EFO_0000713","EFO_0000095","EFO_0005297","EFO_0000764","EFO_0000706","EFO_0000612","HP_0100727","MONDO_0024280"],"count":57},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 6 approved and 45 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1213420","canonicalSmiles":"CN1c2c(oc(=O)n(-c3ccccn3)c2=O)-c2ccccc2S1(=O)=O","inchiKey":"OEHFRZLKGRKFAS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DROXICAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Droxicam"],"crossReferences":{"drugbank":["DB09215"],"chEBI":["76133"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1229525","canonicalSmiles":"Cn1cc(-c2cc3cccnc3[nH]2)c2cc(C(=O)NC(C)(C)CO)ccc21","inchiKey":"XZRYCTLOGNCQDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229525","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06834"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230982","canonicalSmiles":"c1cncc(C2=NCCCC2)c1","inchiKey":"AUBPMADJYNSPOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANABASEINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anabaseine"],"crossReferences":{"chEBI":["80787"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1231206","canonicalSmiles":"Cc1ccc(-c2ccc3c(ccc4sc5c(c43)NC[C@@H](C)NC5=O)n2)cn1","inchiKey":"CMWRPDHVGMHLSZ-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231206","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07430"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231396","canonicalSmiles":"CCCC(N)=O","inchiKey":"DNSISZSEWVHGLH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTYRAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02121"],"chEBI":["50724"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231562","canonicalSmiles":"CCCc1oc(CCC(=O)O)c(C(=O)O)c1C","inchiKey":"WMCQWXZMVIETAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231562","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07517"],"chEBI":["41254"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233528","canonicalSmiles":"CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C","inchiKey":"SXNJFOWDRLKDSF-STROYTFGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOLASERTIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 6727","BI-6727","Bi-6727","Volasertib"],"crossReferences":{"drugbank":["DB12062"]},"childChemblIds":["CHEMBL2105742"],"count":11,"linkedTargets":{"rows":["ENSG00000166851"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_1001257","EFO_0000565","EFO_0000221","EFO_0003893","EFO_0002913","EFO_0000574","EFO_0000222","MONDO_0003541","EFO_0003060","MONDO_0000430"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL1234222","canonicalSmiles":"OC[C@H]1O[C@@H](O)[C@@H](F)[C@@H](O)[C@@H]1O","inchiKey":"ZCXUVYAZINUVJD-AIECOIEWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234222","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04483"],"chEBI":["49152"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234370","canonicalSmiles":"COc1ccc(S(=O)(=O)N2CCCSC(C)(C)[C@H]2C(=O)NO)cc1","inchiKey":"CYYCSKFJEOSZTF-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234370","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02350"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235432","canonicalSmiles":"NCc1c[nH]c2nc(N)[nH]c(=O)c12","inchiKey":"MEYMBLGOKYDGLZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235432","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03304"],"chEBI":["45126"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL123558","canonicalSmiles":"CN1CCN(CCCCN2C(=O)CN(/N=C/c3ccc(-c4ccc(Cl)cc4)o3)C2=O)CC1","inchiKey":"MREBEPTUUMTTIA-PCLIKHOPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZIMILIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azimilide"],"crossReferences":{"Wikipedia":["Azimilide"],"chEBI":["34545"]},"childChemblIds":["CHEMBL3140370","CHEMBL537847"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1235722","canonicalSmiles":"O=P(O)(O)OC[C@H]1O[C@@H](O)[C@H](O)[C@@H]1O","inchiKey":"KTVPXOYAKDPRHY-TXICZTDVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5'-Phosphoribose","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5'-Phosphoribose"],"crossReferences":{"drugbank":["DB04352"],"chEBI":["45425"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237022","drugType":"Antibody","blackBoxWarning":true,"name":"TOCILIZUMAB","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Actemra","Actemra roactemra","Roactemra"],"synonyms":["ATLIZUMAB","BAT-1806","BAT1806","Bat1806","MRA","MSB-11456","MSB11456","R-1569","RG-1569","RHPM-1","RO-4877533","Tocilizumab"],"crossReferences":{"DailyMed":["tocilizumab"],"DrugCentral":["4933"],"Wikipedia":["Tocilizumab"]},"count":55,"approvedIndications":["EFO_0000685","EFO_0000540","EFO_0002609"],"linkedTargets":{"rows":["ENSG00000160712"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","MONDO_0002009","EFO_0003780","EFO_0000756","EFO_0005952","EFO_0000540","EFO_1001148","EFO_1001951","EFO_0000565","EFO_0000096","EFO_0007135","EFO_0000182","EFO_0003884","EFO_0008528","MONDO_0015540","EFO_0000253","EFO_0007541","EFO_1000789","EFO_0000094","EFO_0000692","EFO_0009730","MONDO_0013730","EFO_0009686","EFO_0002618","EFO_1001857","EFO_1000069","MONDO_0008170","EFO_1001466","EFO_1001806","Orphanet_249","MONDO_0044881","EFO_1001119","EFO_1001209","EFO_1001231","EFO_1000986","MONDO_0100096","EFO_0000398","EFO_0001359","EFO_0004256","EFO_0000574","EFO_0007328","EFO_0001378","MONDO_0015564","MONDO_0007254","EFO_1000926","EFO_1001165","EFO_1000637","EFO_1001513","EFO_0008518","EFO_1000044","EFO_1001801","EFO_0000673","EFO_0009321","Orphanet_342","EFO_0000717","EFO_0008586","EFO_0000694","EFO_0000616","EFO_0000685","HP_0001945","EFO_0000478","EFO_0003898","EFO_0000403","EFO_0000222","EFO_0004599","EFO_0003060","EFO_0002609","EFO_0003106","EFO_1001999","EFO_0000095","EFO_0000764","MONDO_0018906","EFO_0005411"],"count":73},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 3 approved and 52 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL126224","canonicalSmiles":"CN(C)CCCn1c2c(c3ccccc31)CCCCCC2","inchiKey":"PLIGPBGDXASWPX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPRINDOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Galatur","Iprindole","Pramindole","Prondol","Tertran","WY-3263"],"crossReferences":{"Wikipedia":["Iprindole"],"drugbank":["DB13496"]},"count":1,"approvedIndications":["EFO_0003761"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for unipolar depression."}
{"id":"CHEMBL1315492","canonicalSmiles":"C=CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C","inchiKey":"VWAUPFMBXBWEQY-ANULTFPQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALTRENOGEST","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Regu-mate"],"synonyms":["A-35957","Altrenogest","RU-2267"],"crossReferences":{"PubChem":["144206907","170465646","29218067"],"drugbank":["DB11372"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL136497","canonicalSmiles":"Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1","inchiKey":"ATCGGEJZONJOCL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IRSOGLADINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Irsogladine","Irsogladine maleate"],"crossReferences":{"PubChem":["29216078"],"drugbank":["DB13056"]},"childChemblIds":["CHEMBL1712923","CHEMBL3198346"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1434","canonicalSmiles":"CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O","inchiKey":"DYKFCLLONBREIL-KVUCHLLUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MINOCYCLINE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Minocycline"],"crossReferences":{"DailyMed":["minocycline%20hydrochloride"],"PubChem":["144207192"],"Wikipedia":["Minocycline"],"drugbank":["DB01017"],"chEBI":["50694"]},"childChemblIds":["CHEMBL1200881"],"count":66,"approvedIndications":["EFO_0000771","EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and is indicated for bacterial disease and infection and has 64 investigational indications."}
{"id":"CHEMBL1437764","canonicalSmiles":"CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1ccnc1","inchiKey":"OWEGWHBOCFMBLP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLIMBAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Climbazole"],"crossReferences":{"PubChem":["144205896","170465557","29217911"],"drugbank":["DB15580"],"chEBI":["83719"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1440","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12","inchiKey":"OFVLGDICTFRJMM-WESIUVDSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRACYCLINE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Achromycin","Achromycin v","Cyclopar","Economycin","Liquamycin","Panmycin","Supramycin","Sustamycin","Tetrabid organon","Tetracyn","Vetquamycin"],"synonyms":["E701","NSC-108579","Tetracycline"],"crossReferences":{"DailyMed":["tetracycline%20hydrochloride"],"PubChem":["144210470"],"TG-GATEs":["48"],"Wikipedia":["Tetracycline"],"drugbank":["DB00759"],"chEBI":["27902"]},"childChemblIds":["CHEMBL454950","CHEMBL1201071"],"count":13,"approvedIndications":["EFO_0000771","EFO_0000544","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and has 3 approved and 10 investigational indications. It was withdrawn in United States."}
{"id":"CHEMBL1451","canonicalSmiles":"C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO","inchiKey":"GFNANZIMVAIWHM-OBYCQNJPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIAMCINOLONE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aristocort","Aristocort A","Delphicort","Kenacort","Kenalog","Triamcinolone","Volon"],"synonyms":["Fluoxiprednisolone","NSC-13397","Triamcinolone"],"crossReferences":{"PubChem":["144204885","144210498","170465188","26751455","47193900","50103941","50103942","77851","855586","90341396"],"Wikipedia":["Triamcinolone"],"drugbank":["DB00620"],"chEBI":["9667"]},"count":31,"approvedIndications":["HP_0006536","EFO_0009552","HP_0001742","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["MONDO_0003005","EFO_1001896","EFO_0010822","EFO_0004683","EFO_1000710","EFO_0007486","EFO_0001365","EFO_1000809","EFO_0000756","MONDO_0002959","EFO_0003778","EFO_0000274","HP_0002043","EFO_0002506","HP_0030834","EFO_0000676","EFO_0004212","HP_0003419","EFO_0004208","EFO_0004616","EFO_0009552","EFO_0009321","EFO_0003940","EFO_0008517","EFO_1001417","EFO_1001250","EFO_0009625","EFO_0005752","EFO_1002005","EFO_0005854","EFO_0000685","HP_0012532","EFO_0003963","EFO_1001466","EFO_0003898","EFO_1001157","EFO_0003770","EFO_0001073","EFO_0003843","HP_0001742","HP_0002315","EFO_0009260","MP_0001845","HP_0006536","EFO_0004192","EFO_1000391","EFO_0010582","HP_0030833","EFO_0000341","EFO_0003766","EFO_0000342","EFO_1000662","EFO_0004264"],"count":53},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and has 4 approved and 27 investigational indications."}
{"id":"CHEMBL1516474","canonicalSmiles":"CCCCCNC(=N)N/N=C/c1c[nH]c2ccc(OC)cc12.O=C(O)/C=C\\C(=O)O","inchiKey":"CPDDZSSEAVLMRY-FEQFWAPWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEGASEROD MALEATE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL76370","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"," Neurotoxicity"],"year":2007},"tradeNames":["Zelmac","Zelnorm"],"synonyms":["HTF 919","Tegaserod maleate"],"crossReferences":{"DailyMed":["tegaserod%20maleate"],"PubChem":["26748994"],"chEBI":["51044"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2002. It was withdrawn in United States  in 2007 due to Cardiotoxicity and  Neurotoxicity."}
{"id":"CHEMBL154111","canonicalSmiles":"O=C(Oc1ccccc1C(=O)O)c1ccccc1O","inchiKey":"WVYADZUPLLSGPU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SALSALATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Disalcid"],"synonyms":["NSC-49171","Salicylsalicylic acid","Salsalate","Sasapyrine"],"crossReferences":{"PubChem":["144205101","170465545","26750031"],"drugbank":["DB01399"],"chEBI":["9014"]},"count":13,"approvedIndications":["HP_0001945","EFO_0003843"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for fever and pain and has 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1571","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CCC(=O)O2","inchiKey":"BPEWUONYVDABNZ-DZBHQSCQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TESTOLACTONE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fludestrin","Teslac"],"synonyms":["NSC-23759","SQ 9538","SQ-9538","Testolactone","Testolactone ciii"],"crossReferences":{"PubChem":["144205129","85554"],"Wikipedia":["Testolactone"],"drugbank":["DB00894"],"chEBI":["9460"]},"count":1,"linkedTargets":{"rows":["ENSG00000137869"],"count":1},"linkedDiseases":{"rows":["MONDO_0000088"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1969 and has 1 investigational indication."}
{"id":"CHEMBL1574","canonicalSmiles":"CC(C)(N)Cc1ccccc1","inchiKey":"DHHVAGZRUROJKS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENTERMINE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Duromine","Ionamin","Phentermine resin 30","Phentermine resin complex"],"synonyms":["Phentermine","Phentermine resin","Phentermine resin complex"],"crossReferences":{"DailyMed":["phentermine%20hydrochloride"],"Wikipedia":["Phentermine"],"drugbank":["DB00191"],"chEBI":["8080"]},"childChemblIds":["CHEMBL1200912"],"count":7,"approvedIndications":["EFO_0001073"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0005204","EFO_0003086","EFO_0003890","EFO_0001074","EFO_0003144","EFO_0001421","EFO_0010445","EFO_0001073","EFO_0000400"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and is indicated for obesity and has 6 investigational indications."}
{"id":"CHEMBL15841","canonicalSmiles":"CCOC(=O)c1ccc(O)cc1","inchiKey":"NUVBSKCKDOMJSU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYLPARABEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E214","Ethyl hydroxybenzoate","Ethyl parahydroxybenzoate","Ethylparaben"],"crossReferences":{"PubChem":["144205514","144210653","170465715","26754637","74198"],"Wikipedia":["Ethylparaben"],"drugbank":["DB13628"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1591074","canonicalSmiles":"c1ccc2sc(SNC3CCCCC3)nc2c1","inchiKey":"DEQZTKGFXNUBJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1591074","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205274","144209634","144213241","29215471"],"drugbank":["DB14200"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1596271","canonicalSmiles":"N=S(=O)([O-])Cc1noc2ccccc12.[Na+]","inchiKey":"QVADSMGRZHVGPL-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1596271","maximumClinicalTrialPhase":0,"parentId":"CHEMBL750","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50107196"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL161381","canonicalSmiles":"Nc1nc(=O)n(C2CSC(CO)O2)cc1F","inchiKey":"XQSPYNMVSIKCOC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMTRICITABINE, (+/-)-","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emtricitabine, (+/-)-","Racivir"],"crossReferences":{"PubChem":["174006968"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1652606","canonicalSmiles":"Cc1oc(=O)oc1COC(=O)N1CC[C@@H](N2CC/C(=C\\C3=C(C(=O)O)N4C(=O)[C@@H](NC(=O)/C(=N/O)c5nsc(N)n5)[C@H]4SC3)C2=O)C1","inchiKey":"HFTSMHTWUFCYMJ-FDNJTQOMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTOBIPROLE MEDOCARIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAL-5788","BAL-5788-001","BAL5788","BAL5788-001","Ceftobiprole medocaril","Ceftobiprole medocaril sodium","Ceftobiprole medocaril sodium salt","RO 65-5788","RO-65-5788","RO-655788"],"childChemblIds":["CHEMBL4297101"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1688829","canonicalSmiles":"CNCC(=O)OCc1cccnc1N(C)C(=O)OC(C)[n+]1cnn(C[C@](O)(c2cc(F)ccc2F)[C@@H](C)c2nc(-c3ccc(C#N)cc3)cs2)c1.Cl.[Cl-]","inchiKey":"QELOMWCWBPJMAS-XFERGYADSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1688829","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1183349","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697767","canonicalSmiles":"OC(CNc1ccccn1)c1ccccc1","inchiKey":"ZEAJXCPGHPJVNP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYRAMIDOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenyramidol"],"crossReferences":{"Wikipedia":["Fenyramidol"],"drugbank":["DB13414"]},"childChemblIds":["CHEMBL1996759"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743070","drugType":"Antibody","blackBoxWarning":false,"name":"SILTUXIMAB","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sylvant"],"synonyms":["CLLB8","CNTO-328","Siltuximab"],"crossReferences":{"DailyMed":["siltuximab"],"DrugCentral":["4977"]},"count":13,"approvedIndications":["EFO_1001332","EFO_0000540","MONDO_0015564"],"linkedTargets":{"rows":["ENSG00000136244"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000681","EFO_0000540","MONDO_0008315","EFO_0001663","EFO_1001332","EFO_0000203","EFO_1000044","MONDO_0100096","EFO_0001359","EFO_0000673","MONDO_0002367","EFO_0001378","MONDO_0015564","EFO_0000692"],"count":15},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 3 approved and 10 investigational indications."}
{"id":"CHEMBL1743083","drugType":"Antibody","blackBoxWarning":false,"name":"TREGALIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BT-061","Tregalizumab"],"count":2,"linkedTargets":{"rows":["ENSG00000010610"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_1001494","MONDO_0004784"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1763","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O","inchiKey":"DMDGGSIALPNSEE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROFLUMETHIAZIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diucardin","Hydrenox","Hydroflumethiazide","Saluron"],"synonyms":["Hydroflumethiazide"],"crossReferences":{"PubChem":["11112295","144203973","170465082","26747027","56422879","855883"],"Wikipedia":["Hydroflumethiazide"],"drugbank":["DB00774"],"chEBI":["5784"]},"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959 and is indicated for cardiovascular disease."}
{"id":"CHEMBL17976","canonicalSmiles":"C=C(C)[C@]12C[C@@H](C)[C@@]34O[C@](Cc5ccccc5)(O[C@@H]1[C@@H]3C=C(COC(=O)Cc1ccc(O)c(OC)c1)C[C@]1(O)C(=O)C(C)=C[C@H]14)O2","inchiKey":"DSDNAKHZNJAGHN-MXTYGGKSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RESINIFERATOXIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Neuroclastin"],"synonyms":["RTX","Resiniferatoxin"],"crossReferences":{"PubChem":["26755740"],"drugbank":["DB06515"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL186720","canonicalSmiles":"CN(C)CCOc1ccccc1Cc1ccccc1","inchiKey":"IZRPKIZLIFYYKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLTOLOXAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenyltoloxamine"],"crossReferences":{"PubChem":["104171393","50103870","50104019"],"Wikipedia":["Phenyltoloxamine"],"drugbank":["DB11160"]},"childChemblIds":["CHEMBL3925724","CHEMBL544235","CHEMBL1586457"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1873475","canonicalSmiles":"C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1","inchiKey":"XYFPWWZEPKGCCK-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBRUTINIB","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Imbruvica"],"synonyms":["CRA-032765","Ibrutinib","PC-32765","PCI 32765","PCI-32765","PCI-32765-00"],"crossReferences":{"DailyMed":["ibrutinib"],"PubChem":["124898784"],"drugbank":["DB09053"],"chEBI":["76612"]},"count":44,"approvedIndications":["EFO_0009441","EFO_0000616","EFO_0000095","EFO_0002616","EFO_1001469","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["MONDO_0009348","EFO_0000681","MONDO_0044887","MONDO_0007254","EFO_1001469","EFO_1001264","EFO_0005952","MONDO_0021063","EFO_1001951","EFO_0000565","EFO_0000309","EFO_1000044","EFO_1001935","EFO_0000096","EFO_1000956","EFO_0000389","MONDO_0008903","MONDO_0004111","EFO_0004289","EFO_1000630","EFO_0000183","MONDO_0002083","EFO_0002617","EFO_0009441","MONDO_0013730","EFO_0000198","EFO_0000616","EFO_0000220","EFO_0002616","EFO_0000403","EFO_1000157","EFO_1001875","EFO_0000222","MONDO_0007576","EFO_0004243","MONDO_0044881","EFO_0003060","MONDO_0008315","EFO_0000311","MONDO_0100096","MONDO_0001023","EFO_0000095","EFO_0007359","EFO_0001421","EFO_0000574","EFO_1001890","EFO_1000560","MONDO_0018906","EFO_0001378","EFO_0000181","EFO_0000519"],"count":51},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 6 approved and 38 investigational indications."}
{"id":"CHEMBL191141","canonicalSmiles":"O=C1c2ccccc2C(=O)N1CCOC(=S)Nc1ccc(Cl)cc1","inchiKey":"BWRRXOIACQYNEK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL191141","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08282"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1923502","canonicalSmiles":"C[C@@H]1CN[C@@H](C2CC2)C(=O)N(C)[C@H](C)C(=O)N[C@H](Cc2ccc(F)cc2)C(=O)NCCCc2ccccc2O1.Cl.O","inchiKey":"ZWIXEQBDJMFCMN-DHHNQDMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ULIMORELIN HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1963249","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TZP-101","Ulimorelin hydrochloride","Ulimorelin hydrochloride monohydrate"],"count":1,"linkedTargets":{"rows":["ENSG00000121853"],"count":1},"linkedDiseases":{"rows":["MONDO_0004567","EFO_1000948"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1951706","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)CC[C@@]3(O)[C@H]1C5","inchiKey":"AABLHGPVOULICI-BRJGLHKUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROMORPHINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydromorphinol"],"crossReferences":{"drugbank":["DB01512"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1987462","canonicalSmiles":"CCCCNCC(O)c1ccc(O)cc1","inchiKey":"RDUHXGIIUDVSHR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAMETHAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bamethan"],"crossReferences":{"PubChem":["29216104"],"drugbank":["DB13206"]},"childChemblIds":["CHEMBL2106636"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL202701","canonicalSmiles":"Nc1nccc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"DBZQFUNLCALWDY-PNHWDRBUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Deazaadenosine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Deazaadenosine"],"crossReferences":{"drugbank":["DB04546"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL207538","canonicalSmiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"AURFZBICLPNKBZ-SYBPFIFISA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BREXANOLONE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zulresso"],"synonyms":["Allopregnan-3.alpha.-ol-20-one","Allopregnanolone","Brexanolone","SAGE-547","SGE-102"],"crossReferences":{"DailyMed":["brexanolone"],"PubChem":["144205595","26756639"],"drugbank":["DB11859"],"chEBI":["50169"]},"count":7,"approvedIndications":["EFO_0007453"],"linkedTargets":{"rows":["ENSG00000109158","ENSG00000145863","ENSG00000187730","ENSG00000011677","ENSG00000151834","ENSG00000145864","ENSG00000166206","ENSG00000022355","ENSG00000182256","ENSG00000102287","ENSG00000094755","ENSG00000268089","ENSG00000113327","ENSG00000163285","ENSG00000186297","ENSG00000163288"],"count":16},"linkedDiseases":{"rows":["EFO_0008526","MONDO_0002050","EFO_0007453","EFO_0000249","EFO_0001358","MONDO_0043510","EFO_0003108","Orphanet_93256","EFO_0003829"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for postpartum depression and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL207729","canonicalSmiles":"CC#CCOc1ccc(S(=O)(=O)N2CCSC(C)(C)[C@@H]2C(=O)NO)cc1","inchiKey":"CVZIHNYAZLXRRS-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL207729","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07964"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2079793","canonicalSmiles":"Nc1nc([O-])c2ncn(CCC(CO)CO)c2n1.[Na+]","inchiKey":"NMQFQBOIHUIALG-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PENCICLOVIR SODIUM","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":0,"parentId":"CHEMBL1540","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Denavir"],"synonyms":["BRL-39123-D","Penciclovir sodium"],"description":"Small molecule drug with a maximum clinical trial phase of I that was first approved in 1996."}
{"id":"CHEMBL2104340","canonicalSmiles":"Nc1nc(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I","inchiKey":"WEVJJMPVVFNAHZ-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBACITABINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ibacitabine"],"crossReferences":{"drugbank":["DB13776"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104415","canonicalSmiles":"CO/N=C1\\C[C@]2(C[C@@H]3C[C@@H](C/C=C(\\C)C[C@@H](C)/C=C/C=C4\\CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)O[C@H](/C(C)=C/C(C)C)[C@H]1C","inchiKey":"YZBLFMPOMVTDJY-LSGXYNIPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOXIDECTIN","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CL 301,423","CL-301,423","CL-301423","Moxidectin"],"crossReferences":{"DailyMed":["moxidectin"],"drugbank":["DB11431"]},"count":4,"approvedIndications":["EFO_0007402","EFO_1001342"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for helminthiasis and onchocerciasis and has 2 investigational indications."}
{"id":"CHEMBL2104900","canonicalSmiles":"O=C(OCCOCCN1CCCCC1)N1c2ccccc2Sc2cccnc21","inchiKey":"DTVJXCOMJLLMAK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPAZETHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-254","Pipazetate","Pipazethate","SK&F 70230-A","SO 15,874"],"crossReferences":{"drugbank":["DB08796"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104967","canonicalSmiles":"CCOCc1cc(OC)c(-c2ccc(C[C@H](NC(=O)c3c(F)cccc3F)C(=O)O)cc2)c(OC)c1","inchiKey":"YLFZHHDVRSYTKT-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIRATEGRAST","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Firategrast","SB-683699"],"crossReferences":{"drugbank":["DB12732"]},"count":2,"linkedTargets":{"rows":["ENSG00000150093","ENSG00000115232","ENSG00000139626"],"count":3},"linkedDiseases":{"rows":["EFO_0003885","EFO_0003929"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105224","canonicalSmiles":"CN1CC[C@]23c4c5ccc(OCCN6CCOCC6)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5","inchiKey":"GPFAJKDEDBRFOS-FKQDBXSBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOLCODINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dia-tuss","Ethnine simplex","Evaphol","Evaphol strong","Galenphol","Gppe linct","Pavacol-d","Pholcomed fte","Sancos co","Tixylix daytime","Tixylix dry cough","Tixylix night cough","Tixylix night-time"],"synonyms":["Pholcodine"],"crossReferences":{"drugbank":["DB09209"],"chEBI":["53579"]},"count":1,"approvedIndications":["HP_0012735"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cough."}
{"id":"CHEMBL2105544","canonicalSmiles":"CC(Cc1ccccc1)/N=C/C(Cl)(Cl)Cl","inchiKey":"VBZDETYCYXPOAK-OVCLIPMQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMPHECLORAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amfecloral","Amphecloral"],"crossReferences":{"drugbank":["DB08924"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105639","canonicalSmiles":"CC[C@H](C)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C","inchiKey":"RCTCWZRPYFBGLQ-KVBIMOIYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DIRUCOTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dirucotide","MBP-8298","MBP8298","SF328"],"childChemblIds":["CHEMBL2105640"],"count":3,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2105667","canonicalSmiles":"Cc1cc(F)ccc1[C@H]1C[C@@H](N2CCN3C(=O)CC[C@H]3C2)CCN1C(=O)N(C)[C@H](C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1","inchiKey":"XWNBGDJPEXZSQM-VZOBGQTKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORVEPITANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW-823296X","GW823296X","Gw823296","Orvepitant"],"crossReferences":{"drugbank":["DB12427"]},"childChemblIds":["CHEMBL2105668"],"count":3,"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","HP_0012735","MONDO_0002009","EFO_0001358"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2106829","canonicalSmiles":"Cc1ccccc1-n1c(C)nc2ccccc2c1=O.Cl","inchiKey":"KJUHIXIWKSVBKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHAQUALONE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL282052","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Misuse"],"year":1984},"tradeNames":["Optimil","Parest"],"synonyms":["Methaqualone hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States  in 1984 due to Misuse."}
{"id":"CHEMBL2107341","canonicalSmiles":"OCCOCCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1","inchiKey":"NKZTZAQIKKGTDB-QPLCGJKRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FISPEMIFENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fispemifene","HM-101","HM-101a"],"crossReferences":{"drugbank":["DB06640"]},"count":4,"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["MONDO_0002146","EFO_0004714","EFO_0004234","MONDO_0018555"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2107372","canonicalSmiles":"CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](OC(=O)C3CCCC3)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)C)c4cccs4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C","inchiKey":"SLGIWUWTSWJBQE-VLCCYYTCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMOTAXEL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MST-997","Simotaxel"],"crossReferences":{"drugbank":["DB15384"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107381","canonicalSmiles":"CC(=O)OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O","inchiKey":"AUFUWRKPQLGTGF-FMKGYKFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URIDINE TRIACETATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vistogard","Xuriden"],"synonyms":["PN-401","PN401","RG-2133","RG2133","Uridine triacetate"],"crossReferences":{"DailyMed":["uridine%20triacetate"],"drugbank":["DB09144"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 5 investigational indications."}
{"id":"CHEMBL2107531","canonicalSmiles":"CC(SC(=O)c1cccs1)C(=O)NCC(=O)O","inchiKey":"JNYSEDHQJCOWQU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STEPRONIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Stepronin","Tiofacic"],"crossReferences":{"drugbank":["DB01423"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107726","canonicalSmiles":"[O-][n+]1cccc(/C(Cl)=N/OC[C@H](O)CN2CCCCC2)c1","inchiKey":"SGEIEGAXKLMUIZ-XUVDNFPMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARIMOCLOMOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arimoclomol","BRX-220 FREE BASE"],"childChemblIds":["CHEMBL4298149"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2108326","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"ALICAFORSEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alicaforsen"],"count":4,"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2108378","drugType":"Antibody","blackBoxWarning":false,"name":"EDOBACOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Edobacomab","Xomen-E5"],"description":"Antibody drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2108469","drugType":"Protein","blackBoxWarning":false,"name":"MUPLESTIM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hemokine"],"synonyms":["Interleukin-3","Interleukin-3 muplestim","Muplestim","SDZ ILE 964","SDZ-ILE-964"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108741","drugType":"Unknown","blackBoxWarning":false,"name":"SIMETICONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Asilone windcheaters","Infacol","Phazyme","Wind-eze","Windsetlers"],"synonyms":["Simeticone"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2108752","drugType":"Unknown","blackBoxWarning":false,"name":"PEGAPTANIB OCTASODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pegaptanib","Pegaptanib octasodium"],"crossReferences":{"DrugCentral":["4905"]},"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108766","drugType":"Unknown","blackBoxWarning":false,"name":"PYRETHRUM EXTRACT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyrethrum","Pyrethrum extract"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108930","drugType":"Unknown","blackBoxWarning":false,"name":"CRANBERRY LIQUID PREPARATION","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cranberry liquid preparation"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109084","drugType":"Enzyme","blackBoxWarning":false,"name":"DESMOTEPLASE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Desmoteplase","Dspa desmoteplase","RDSPA ALPHA 1"],"count":1,"linkedTargets":{"rows":["ENSG00000122194"],"count":1},"linkedDiseases":{"rows":["HP_0002140","EFO_0000712"],"count":2},"description":"Enzyme drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109162","drugType":"Small molecule","blackBoxWarning":false,"name":"HEMOGLOBIN GLUTAMER","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hemoglobin glutamer","Hemoglobin glutamer (bovine)"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109205","drugType":"Protein","blackBoxWarning":false,"name":"NONACOG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Benefix"],"synonyms":["Nonacog alfa","Nonacog gamma"],"crossReferences":{"DrugCentral":["5163"]},"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109390","drugType":"Antibody","blackBoxWarning":false,"name":"MAB-425","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MAB-425","Mab-425"],"count":1,"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000326"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109399","drugType":"Antibody","blackBoxWarning":false,"name":"T-DM1","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["T-DM1"],"count":1,"linkedTargets":{"rows":["ENSG00000141736"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109449","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-570","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-570","Medi 570","Medi-570"],"count":1,"linkedTargets":{"rows":["ENSG00000163600"],"count":1},"linkedDiseases":{"rows":["EFO_0002690"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL213758","canonicalSmiles":"O=C(O)COc1c(C(=O)O)sc(-c2ccccc2)c1Br","inchiKey":"MVDWLRCTJUXCCB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL213758","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07130"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2146088","canonicalSmiles":"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12.Cl.Cl","inchiKey":"NNKXWRRDHYTHFP-HZQSTTLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUININE DIHYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL170","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Quinine dihydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2146123","canonicalSmiles":"C=C1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12.Cl","inchiKey":"VZQARNDJLLWXGL-CCHMMTNSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHACYCLINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL249837","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rondomycin"],"synonyms":["Metacycline hydrochloride","Methacycline hydrochloride","NSC-356465"],"crossReferences":{"PubChem":["144204093","170465224"],"chEBI":["6806"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL2146146","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2.O=S(=O)(O)O","inchiKey":"VJFQPODMEGSXHC-RIMUKSHESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATROPINE SULFATE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL517712","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atropine","Atropine sulfate","Atropine sulfate ansyr plastic syringe","Atropine sulfate lifeshield abboject syringe","Isopto atropine"],"synonyms":["Atropine sulfate","Atropine sulfate anhydrous","Atropine sulfate hydrate","Atropine sulfate monohydrate","Atropine sulphate","NSC-26671"],"crossReferences":{"DailyMed":["atropine%20sulfate"]},"count":8,"approvedIndications":["EFO_0005854","HP_0004398","EFO_0002508","HP_0011499","EFO_0003956"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072","ENSG00000168539"],"count":3},"linkedDiseases":{"rows":["EFO_0005854","HP_0004398","EFO_0005758","EFO_0002508","EFO_0005323","HP_0000545","EFO_0010581","HP_0011499","HP_0002315","EFO_0003956"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and has 5 approved and 3 investigational indications."}
{"id":"CHEMBL21869","canonicalSmiles":"O=C(Nc1ccc(Br)cc1)c1cc(Br)ccc1O","inchiKey":"CTFFKFYWSOSIAA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIBROMSALAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["Dibromsalan"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States."}
{"id":"CHEMBL219484","canonicalSmiles":"N=C(N)NC(=N)Nc1cc(C(F)(F)F)ccc1Cl","inchiKey":"IGFTZEOFHWPCDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL219484","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08478"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2218893","canonicalSmiles":"CN(C)C(=O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1ccc(O)c(CCO)c1)CC2.CN(C)C(=O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1ccc(O)c(CCO)c1)CC2.O=S(=O)(O)O","inchiKey":"VPCOODFYDJWLHD-YMZXMBPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEDORADRINE SULFATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2111083","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bedoradrine sulfate","KUR-1246","MN-221"],"count":3,"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0008590","EFO_0000270","EFO_0000341"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL222645","canonicalSmiles":"Cc1onc(-c2c(F)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12","inchiKey":"UIOFUWFRIANQPC-JKIFEVAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLOXACILLIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abboflox","Floxapen","Fluclomix-250","Fluclomix-500","Flucloxin","Galfloxin","Ladropen","Rimaflox","Stafoxil","Staphlipen","Zoxin 250","Zoxin 500"],"synonyms":["BRL 2039","BRL-2039","Floxacillin","Flucloxacillin","Flucloxacillin sodium"],"crossReferences":{"Wikipedia":["Flucloxacillin"],"drugbank":["DB00301"],"chEBI":["5098"]},"childChemblIds":["CHEMBL3187256","CHEMBL283053"],"count":6,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for bacterial disease and has 5 investigational indications."}
{"id":"CHEMBL2286758","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)CO)OC(=O)CCCCCCCCCCCCCCC","inchiKey":"BIABMEZBCHDPBV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2286758","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02043"],"chEBI":["60724"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL23013","canonicalSmiles":"N=C(N)c1ccc(OCCCOc2ccc(C(=N)N)cc2)cc1","inchiKey":"WTFXJFJYEJZMFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPAMIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["M&B 782 [AS ISETHIONATE]","Propamidine"],"crossReferences":{"PubChem":["144206602"],"Wikipedia":["Propamidine"],"drugbank":["DB13296"],"chEBI":["87462"]},"childChemblIds":["CHEMBL3216426"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2368861","canonicalSmiles":"CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5.Cl","inchiKey":"UAIXRPCCYXNJMQ-HPRIMLMLSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUPRENORPHINE HYDROCHLORIDE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL511142","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Belbuca","Buprenex","Buprenorphine hydrochloride","Espranor","Gabup","Natzon","Prefibin","Probuphine","Subutex"],"synonyms":["Buprenorphine hydrochloride","Buprenorphine hydrochloride ciii","CL 112,302","CL-112302","M-6029","NIH 8805","NIH-8805","RX 6029-M HCL","RX-6029-M HCL","SCH-028444","UM 952","UM-952"],"crossReferences":{"DailyMed":["buprenorphine%20hydrochloride"]},"count":2,"linkedTargets":{"rows":["ENSG00000082556","ENSG00000112038"],"count":2},"linkedDiseases":{"rows":["EFO_0003890","EFO_0005611"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL249973","canonicalSmiles":"O=C(O)Cn1c(C(=O)Nc2nc(-c3ccccc3Cl)cs2)cc2ccccc21","inchiKey":"ILNRQFBVVQUOLP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINTITRIPT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lintitript","SR-27897"],"crossReferences":{"PubChem":["144206134","170466345","50112865"],"drugbank":["DB04867"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL251990","canonicalSmiles":"CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](N[11C](C)=O)[C@@H](N)C1","inchiKey":"VSZGPKBBMSAYNT-OLQDSRGESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL251990","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1229","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL253951","canonicalSmiles":"O=C(O/N=C/c1ccc(O)cc1)C1CCCCC1","inchiKey":"YWZBYSBZDQWXGQ-XNTDXEJSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL253951","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08333"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL257704","canonicalSmiles":"CN(C)CCO/N=C(/C=C/c1ccc(O)cc1)c1ccccc1F","inchiKey":"VAIOZOCLKVMIMN-PRJWTAEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPLIVANSERIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eplivanserin","SR-46349","SR46349"],"crossReferences":{"drugbank":["DB12177"]},"childChemblIds":["CHEMBL2103845"],"count":1,"linkedTargets":{"rows":["ENSG00000102468"],"count":1},"linkedDiseases":{"rows":["EFO_0004698"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL259972","canonicalSmiles":"COc1ccc(-c2noc(CC(=O)O)c2-c2ccc(OC)cc2)cc1","inchiKey":"DJEIHHYCDCTAAH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOFEZOLAC","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mofezolac"],"crossReferences":{"PubChem":["144206111","50112817"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL268164","canonicalSmiles":"CCC1(C2=CCCCC2)C(=O)NC(=O)NC1=O","inchiKey":"WTYGAUXICFETTC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOBARBITAL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Norway"],"classes":["Misuse"],"year":1980},"tradeNames":["Phanodorn"],"synonyms":["Cyclobarbital","Hexemal"],"crossReferences":{"Wikipedia":["Cyclobarbital"],"drugbank":["DB13737"]},"childChemblIds":["CHEMBL2106556"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Norway  in 1980 due to Misuse."}
{"id":"CHEMBL286738","canonicalSmiles":"NS(=O)(=O)Oc1ccc2c3c(c(=O)oc2c1)CCCCC3","inchiKey":"DSLPMJSGSBLWRE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IROSUSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["667 COUMATE","667-COUMATE","BN 83495","BN-83495","BN83495","Irosustat","STX 64","STX-64","STX64"],"crossReferences":{"drugbank":["DB02292"]},"count":4,"linkedTargets":{"rows":["ENSG00000101846"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","MONDO_0011962","MONDO_0007254","MONDO_0008315"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL293526","canonicalSmiles":"Cc1oc(-c2ccccc2)nc1CCOc1ccc(CC2C(=O)NOC2=O)cc1","inchiKey":"QBQLYIISSRXYKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REGLITAZAR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Reglitazar"],"crossReferences":{"drugbank":["DB04971"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL296939","canonicalSmiles":"O=C(COc1ccc(Cl)cc1C(=O)c1ccccc1)Nc1ccccc1","inchiKey":"DTGVSZSMDOMAEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GF-128590","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GF-128590"],"crossReferences":{"drugbank":["DB07826"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL29757","canonicalSmiles":"N[C@H](CC(=O)O)C(=O)O","inchiKey":"CKLJMWTZIZZHCS-UWTATZPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-ASPARTATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-Aspartic Acid","D-aspartate"],"crossReferences":{"PubChem":["11110794","11113408","144204455","26751646"],"drugbank":["DB02655"],"chEBI":["17364"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL307679","canonicalSmiles":"Nc1ccn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)n1","inchiKey":"IERHLVCPSMICTF-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Cytidine 5'-Phosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cytidine 5'-Phosphate","Cytidine-5'-Monophosphate"],"crossReferences":{"Wikipedia":["Cytidine_monophosphate"],"drugbank":["DB03403"],"chEBI":["17361"]},"childChemblIds":["CHEMBL1627075"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL307697","canonicalSmiles":"O=[N+]([O-])c1ccc(NN=C(c2ccc(O)cc2)c2ccc(O)cc2)c([N+](=O)[O-])c1","inchiKey":"YOQPCWIXYUNEET-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIVIFENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-007","Sivifene"],"crossReferences":{"drugbank":["DB05686"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3085504","canonicalSmiles":"Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1.O=S(=O)(O)O","inchiKey":"WUIABRMSWOKTOF-OYALTWQYSA-O","drugType":"Small molecule","blackBoxWarning":true,"name":"BLEOMYCIN SULFATE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL403664","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Blenoxane","Bleomycin sulfate"],"synonyms":["Bleomycin sulfate","Bleomycins sulfate"],"count":31,"approvedIndications":["EFO_0000707","EFO_0000181"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and is indicated for head and neck squamous cell carcinoma and squamous cell carcinoma and has 29 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL308954","canonicalSmiles":"Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br","inchiKey":"PYGWGZALEOIKDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETRAVIRINE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Intelence"],"synonyms":["Etravirine","R-165335","R165335","TMC 125","TMC-125","TMC125"],"crossReferences":{"DailyMed":["etravirine"],"Wikipedia":["Etravirine"],"drugbank":["DB06414"],"chEBI":["63589"]},"count":6,"approvedIndications":["EFO_0000764","EFO_0000180","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 3 approved and 3 investigational indications."}
{"id":"CHEMBL316040","canonicalSmiles":"COc1ccc(-n2nc(CCC(=O)N(C)O)cc2-c2ccc(Cl)cc2)cc1","inchiKey":"XYKWNRUXCOIMFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEPOXALIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ORF 20485","RWJ 20485","Tepoxalin"],"crossReferences":{"PubChem":["170466265"],"drugbank":["DB11466"],"chEBI":["76277"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3182465","canonicalSmiles":"CN1CCC[C@H]1c1cccnc1.CN1CCC[C@H]1c1cccnc1.O=S(=O)(O)O","inchiKey":"IECQULMJVNSKDB-RCWTXCDDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3182465","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212671"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3221419","canonicalSmiles":"C/C=C\\C=C\\[C@@H]1O[C@](O)([C@H](CC)C(=O)NC/C=C/C=C(\\C)[C@@H](OC)[C@@H](C)[C@@H]2O[C@H](/C=C/C=C/C=C(\\C)C(=O)c3c(O)ccn(C)c3=O)[C@H](O)[C@@H]2O)[C@H](O)[C@H](O)C1(C)C","inchiKey":"NTAHMPNXQOYXSX-WKSONYIQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3221419","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04124"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL327715","canonicalSmiles":"N=C(N)c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3O)nc2c1","inchiKey":"LMGQGPVCSYOMNS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL327715","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01725"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3542265","canonicalSmiles":"CC(C)OC(=O)N[C@H]1Cc2c(n(Cc3ccccn3)c3ccc(C#N)cc23)C1","inchiKey":"IHIWYQYVBNODSV-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY2452473","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2452473","LY2452473","Ly2452473","OPK-88004","TT-701"],"crossReferences":{"drugbank":["DB12573"]},"childChemblIds":["CHEMBL3542296"],"count":3,"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0004234","EFO_0000284","MONDO_0008315"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3544986","canonicalSmiles":"CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC.N=C(N)NCCC[C@H](N)C(=O)O","inchiKey":"RYCSJJXKEWBUTI-YDYAIEMNSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PERINDOPRIL ARGININE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1581","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Perindopril arginine"],"crossReferences":{"DailyMed":["perindopril%20arginine"],"chEBI":["77655"]},"count":1,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2015 and is indicated for hypertension. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3545036","canonicalSmiles":"Cc1cc(C)c(N)c(C#Cc2cccc(F)c2)n1","inchiKey":"MEDCLNYIYBERKO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RASEGLURANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADX-10059","ADX10059","Adx-10059","Adx10059","Raseglurant"],"childChemblIds":["CHEMBL3894333"],"count":2,"linkedTargets":{"rows":["ENSG00000168959"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","EFO_0003821"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545104","drugType":"Protein","blackBoxWarning":false,"name":"MODIMELANOTIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-719","Ap214","Modimelanotide","ZP-1480","ZP1480"],"count":2,"linkedTargets":{"rows":["ENSG00000124089","ENSG00000258839"],"count":2},"linkedDiseases":{"rows":["HP_0001919","EFO_0009833","EFO_0001666"],"count":3},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545147","drugType":"Small molecule","blackBoxWarning":false,"name":"IMD-2560","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imd-2560"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545268","drugType":"Small molecule","blackBoxWarning":false,"name":"MLN3126","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mln3126"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545307","canonicalSmiles":"Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1","inchiKey":"QHADVLVFMKEIIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MERESTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2801653","LY2801653","Ly-2801653","Merestinib"],"crossReferences":{"drugbank":["DB12381"]},"count":8,"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_1001951","EFO_0002618","MONDO_0003060","EFO_0000389","MONDO_0007254","EFO_1001469","MONDO_0024880","EFO_0003060","EFO_1001934","EFO_0000311"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3545359","drugType":"Small molecule","blackBoxWarning":false,"name":"ARRY-300","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arry-300","MET-300"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545412","drugType":"Small molecule","blackBoxWarning":false,"name":"K-877","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["K-877"],"count":3,"linkedTargets":{"rows":["ENSG00000186951"],"count":1},"linkedDiseases":{"rows":["EFO_0004211","EFO_0003095","Orphanet_309005"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545424","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-8186","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD8186","Azd 8186","Azd-8186"],"count":6,"linkedTargets":{"rows":["ENSG00000171608","ENSG00000051382"],"count":2},"linkedDiseases":{"rows":["MONDO_0001056","MONDO_0007254","EFO_0000196","EFO_0000305","MONDO_0008315","EFO_0003060"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL354739","canonicalSmiles":"Cc1ccc(NNC(=O)[C@@H](O)[C@H](N)CC2CCCCC2)cc1","inchiKey":"IQMLIGOOOFEBAH-CVEARBPZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL354739","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03086"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL359788","canonicalSmiles":"O=C1N[C@@H](Cc2ccc(O)cc2)C(=O)N2CCC[C@@H]12","inchiKey":"LSGOTAXPWMCUCK-RYUDHWBXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL359788","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04520"],"chEBI":["6631"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL360520","canonicalSmiles":"NC(=O)c1nn(-c2ccc(S(N)(=O)=O)cc2)c2c1ccc1[nH]ncc12","inchiKey":"HGAKLLFPOGATII-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL360520","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08527"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL368238","canonicalSmiles":"CC(C)N1CCC(NC(=O)c2cc3ccccc3n2CC(=O)Nc2ccc(Cl)cc2)CC1","inchiKey":"BDLMBQRBNPDCSS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL368238","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07974"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3697617","canonicalSmiles":"Cc1cc(Oc2ncccc2C(F)(F)F)ccc1-c1c(C)c(=O)[nH]c(=O)n1C","inchiKey":"AKQXQLUNFKDZBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAVAPADON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06649751","Pf-06649751","Tavapadon"],"crossReferences":{"drugbank":["DB14899"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707266","canonicalSmiles":"CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1.O=C(O)CCC(=O)O","inchiKey":"NHANOMFABJQAAH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIBOCICLIB SUCCINATE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3545110","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kisqali"],"synonyms":["LEE011-BBA","Ribociclib succinate"],"crossReferences":{"DailyMed":["ribociclib%20succinate"]},"count":2,"approvedIndications":["EFO_0000616","EFO_0000305"],"linkedTargets":{"rows":["ENSG00000135446","ENSG00000105810"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000305"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for breast carcinoma and neoplasm."}
{"id":"CHEMBL3707282","canonicalSmiles":"O=C([O-])c1cc(=O)[nH]c(=O)[nH]1.O=C([O-])c1cc(=O)[nH]c(=O)[nH]1.[Mg+2]","inchiKey":"QWLHYYKDLOVBNV-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM OROTATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Magnerot classic"],"synonyms":["Magnesium orotate"],"crossReferences":{"DrugCentral":["4594"],"drugbank":["DB13786"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3707387","canonicalSmiles":"O.O=O.[O-][Cl+][O-].[O-][Cl+][O-].[O-][Cl+][O-].[O-][Cl+][O-]","inchiKey":"VOWOEBADKMXUBU-UHFFFAOYSA-J","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRACHLORODECAOXIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4299960","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DAC N-055","Dac n-055","Tetrachlorodecaoxide","WF-10"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL376897","canonicalSmiles":"C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21","inchiKey":"LZCOQTDXKCNBEE-IKIFYQGPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHSCOPOLAMINE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Methylscopolamine"],"crossReferences":{"DailyMed":["methscopolamine%20bromide"],"Wikipedia":["Methylscopolamine_bromide"],"drugbank":["DB11315"]},"childChemblIds":["CHEMBL1506225","CHEMBL1354199"],"count":1,"approvedIndications":["EFO_0010282"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282","EFO_0005758"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL391087","canonicalSmiles":"CCCOc1ccc(-c2csc(-c3ccccc3Cl)c2CC(=O)NC(=N)N)cc1","inchiKey":"VZSMTBLDWPKVRW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL391087","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07089"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3928407","canonicalSmiles":"N#Cc1c(N)nc(N)nc1N[C@H](c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cccnc1)C1CC1","inchiKey":"XDSXYMOZKDUASY-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GS-9901","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gs 9901","Gs-9901"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3989693","canonicalSmiles":"CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1.CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"VNVNZKCCDVFGAP-NMFAMCKASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVALBUTEROL TARTRATE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1002","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xopenex","Xopenex hfa"],"synonyms":["Levalbuterol tartrate","Levosalbutamol tartrate"],"crossReferences":{"DailyMed":["levalbuterol%20tartrate"]},"count":2,"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000270","HP_0025428"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 2 investigational indications."}
{"id":"CHEMBL3989759","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)c3c1c2[C@@H](N)CC3.CS(=O)(=O)O.O.O","inchiKey":"FXQZOHBMBQTBMJ-MWPGLPCQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EXATECAN MESYLATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1614650","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DX-8951F","Exatecan mesilate dihydrate","Exatecan mesilate hydrate","Exatecan mesylate","Exatecan methanesulfonate dihydrate"],"count":15,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 15 investigational indications."}
{"id":"CHEMBL3989908","canonicalSmiles":"CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1","inchiKey":"DYLUUSLLRIQKOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ENASIDENIB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AG-221","Ag 221","CC-90007 Free Base","Enasidenib"],"crossReferences":{"DailyMed":["enasidenib%20mesylate"],"drugbank":["DB13874"]},"childChemblIds":["CHEMBL3989931"],"count":9,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000182054"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000565","EFO_0000616","EFO_1001779","EFO_0001421","EFO_0000222","EFO_0001378","MONDO_0044881","EFO_0000311"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for neoplasm and cancer and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989951","canonicalSmiles":"O[C@H](C[C@H]1c2c(F)cccc2-c2cncn21)[C@H]1CC[C@H](O)CC1","inchiKey":"YGACXVRLDHEXKY-WXRXAMBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAVOXIMOD","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GDC-0919","IDO-IN-7","NLG-919","NLG919","Navoximod","RG-6078","RG6078","RO-7077339","RO7077339","RO7077339-001"],"crossReferences":{"drugbank":["DB15439"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3990026","drugType":"Enzyme","blackBoxWarning":false,"name":"ELAPEGADEMASE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Revcovi"],"synonyms":["EZN-2279","Elapegademase","Elapegademase-lvlr"],"crossReferences":{"DailyMed":["elapegademase-lvlr"]},"count":1,"approvedIndications":["Orphanet_183660"],"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for severe combined immunodeficiency."}
{"id":"CHEMBL406381","canonicalSmiles":"CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl","inchiKey":"VPBYZLCHOKSGRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KRN-633","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KRN-633","Krn-633"],"crossReferences":{"PubChem":["174006598"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL408500","canonicalSmiles":"CCCCCCCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO","inchiKey":"FTSCEGKYKXESFF-LXTVHRRPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N-(N-Nonyl)Deoxynojirimycin","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-(N-Nonyl)Deoxynojirimycin","N-Nonyl 1-Deoxynojirimycin","N-Nonyl-Deoxynojirimycin","N-Nonyldeoxynojirimycin"],"crossReferences":{"PubChem":["50130528"],"drugbank":["DB08283"],"chEBI":["76399"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4085102","canonicalSmiles":"CC(=O)O.CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O","inchiKey":"OCSYZCHOCWAFRR-BQABOTKESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4085102","maximumClinicalTrialPhase":0,"parentId":"CHEMBL525076","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL412989","canonicalSmiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)O2)c(=O)[nH]c1=O","inchiKey":"YSYKRGRSMLTJNL-URARBOGNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL412989","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Thymidine_diphosphate_glucose"],"drugbank":["DB03751"],"chEBI":["15700"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL415284","canonicalSmiles":"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5","inchiKey":"UIQMVEYFGZJHCZ-SSTWWWIQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALORPHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nalorphine"],"crossReferences":{"PubChem":["50113068"],"Wikipedia":["Nalorphine"],"drugbank":["DB11490"],"chEBI":["7458"]},"childChemblIds":["CHEMBL1908349"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297354","canonicalSmiles":"Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)nc1C(N)=O","inchiKey":"YXFNPRHZMOGREC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-7687","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD7687","Azd 7687","Azd-7687","Azd7687"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297379","canonicalSmiles":"C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1C[C@H]1O[C@@H](c3ccco3)O[C@]12C(=O)C[18F]","inchiKey":"VJKRBRUNEOHPBS-JQKUZGBFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUOROFURANYLNORPROGESTERONE F-18","maximumClinicalTrialPhase":1,"parentId":"CHEMBL378031","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["F18-ffnp","Fluorofuranylnorprogesterone f-18"],"crossReferences":{"drugbank":["DB15282"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297436","canonicalSmiles":"Cc1nc(-c2cccnc2)sc1C(=O)Nc1ccccc1-c1cn2c(CN3CCOCC3)csc2n1","inchiKey":"LAMQVIQMVKWXOC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SRT-2104","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SRT2104","Srt-2104","Srt2104"],"crossReferences":{"drugbank":["DB12186"]},"count":7,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4297450","canonicalSmiles":"COc1cc(CO)ccc1O","inchiKey":"ZENOXNGFMSCLLL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VANILLYL ALCOHOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 3737","NSC-3993","V-0018","V0018","Vanillyl alcohol"],"crossReferences":{"drugbank":["DB12087"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297452","canonicalSmiles":"C[N+](C)(C)CCO.[O-]c1ccc(Cc2cc3cccccc-3c2)cc1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"UKOOBSDARBTSHN-NGOMLPPMSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"YM-543","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2397450","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-543","YM 543","YM543","Ym-543","Ym543"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297549","drugType":"Enzyme","blackBoxWarning":false,"name":"HUMAN C1-ESTERASE INHIBITOR","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Berinert","C1-inhibitor, plasma derived","Cinryze","Human c1-esterase inhibitor","RVG-19303"],"count":4,"approvedIndications":["Orphanet_91378"],"linkedTargets":{"rows":["ENSG00000164344","ENSG00000182326","ENSG00000088926","ENSG00000131187"],"count":4},"linkedDiseases":{"rows":["EFO_0004256","EFO_0005532","EFO_1002048","Orphanet_91378"],"count":4},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hereditary angioedema and has 3 investigational indications."}
{"id":"CHEMBL4297568","drugType":"Unknown","blackBoxWarning":false,"name":"BMS-986156","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-986156"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297724","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"CERTOPARIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Certoparin"],"count":3,"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297746","drugType":"Unknown","blackBoxWarning":false,"name":"ENADENOTUCIREV","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enadenotucirev"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297749","drugType":"Unknown","blackBoxWarning":false,"name":"EPOFOLATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-753493","BMS753493","Epofolate"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297758","drugType":"Unknown","blackBoxWarning":false,"name":"GDC-0927","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GDC-0927","Gdc-0927","RG-6047"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297915","canonicalSmiles":"Cc1ccc(S(=O)(=O)NO)o1","inchiKey":"LIXKIXWSKOENAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIMLANOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986231","Bms-986231","CXL-1427","Cimlanod","Cxl-1427"],"crossReferences":{"drugbank":["DB14983"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298061","drugType":"Unknown","blackBoxWarning":false,"name":"LEXAPTEPID PEGOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lexaptepid pegol","NOX-H94","Nox-h94"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298064","drugType":"Small molecule","blackBoxWarning":false,"name":"BERDAZIMER SODIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Berdazimer sodium","NVN-1000","NVN1000","Nvn1000"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298195","drugType":"Antibody","blackBoxWarning":false,"name":"NARSOPLIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Narsoplimab","OMS-721","OMS00620646","OMS620646","OMS721"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4303232","canonicalSmiles":"CN(C)CCn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3csc(N)n3)[C@H]2SC1.Cl.Cl","inchiKey":"BWRRTAXZCKVRON-DGPOFWGLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303232","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1296","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL430488","canonicalSmiles":"COc1ccc2c(c1)N(C(=O)OC(C)C)[C@@H](CSC)C(=S)N2","inchiKey":"GWKIPRVERALPRD-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALVIRALINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HBY 097","HBY-097","Hby 097","Talviraline"],"crossReferences":{"drugbank":["DB07885"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL443605","canonicalSmiles":"CCCCCCc1ccc(O)cc1O","inchiKey":"WFJIVOKAWHGMBH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXYLRESORCINOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sucrets"],"synonyms":["Hexylresorcinol"],"crossReferences":{"PubChem":["144204653","144209461","144210675","170465471","17388779","26747321","26752939","56436657","68346"],"Wikipedia":["Hexylresorcinol"],"drugbank":["DB11254"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL44426","canonicalSmiles":"Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCC3)cc2)c2ccc(O)cc12","inchiKey":"JICOGKJOQXTAIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPENDOXIFENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ERA-923","Era-923","Pipendoxifene"],"crossReferences":{"drugbank":["DB05414"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL44875","drugType":"Small molecule","blackBoxWarning":false,"name":"BIBROCATHOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bibrocathin","Bibrocathol","Bismucatebrol","Cabis bromatum"],"crossReferences":{"Wikipedia":["Bibrocathol"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4539157","canonicalSmiles":"C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN([11CH3])C(=O)c2ccc(F)cc21","inchiKey":"IIXWYSCJSQVBQM-RBISCYFJSA-N","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4539157","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3286830","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594347","drugType":"Protein","blackBoxWarning":false,"name":"CLERVONAFUSP ALFA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clervonafusp alfa","VAL-1221","Val-1221"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594393","canonicalSmiles":"O=C([O-])CCCO.O=C([O-])CCCO.[Ca+2]","inchiKey":"AZRRVLSHRWGNRS-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM OXYBATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1342","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Calcium oxybate"],"crossReferences":{"DailyMed":["calcium%20oxybate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020."}
{"id":"CHEMBL460026","canonicalSmiles":"CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCC(=O)O","inchiKey":"JAZBEHYOTPTENJ-JLNKQSITSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ICOSAPENT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EPA 45G","Eicosapentaenoic acid","Icosapent","Omega-3 marine triglycerides"],"crossReferences":{"PubChem":["144205544","26754924","26754925","50110832"],"Wikipedia":["Eicosapentaenoic_acid"],"drugbank":["DB00159"],"chEBI":["28364"]},"count":46,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 46 investigational indications."}
{"id":"CHEMBL460282","canonicalSmiles":"CS(=O)(=O)OC[C@@H](OS(C)(=O)=O)[C@@H](O)[C@H](O)[C@@H](COS(C)(=O)=O)OS(C)(=O)=O","inchiKey":"UUVIQYKKKBJYJT-ZYUZMQFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MANNOSULFAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mannosulfan","R-52"],"crossReferences":{"drugbank":["DB13334"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL47072","canonicalSmiles":"CCC(=O)C1(c2cccc(O)c2)CCN(C)CC1","inchiKey":"ALFGKMXHOUSVAD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KETOBEMIDONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cetobemidone","Cliradon","Cymidon","IDS-NK-001","IDS-NK-001(SECT.3)","Ketobemidone","Ketodur","Ketogan","Ketorax","NSC-117863"],"crossReferences":{"Wikipedia":["Ketobemidone"],"drugbank":["DB06738"],"chEBI":["6125"]},"childChemblIds":["CHEMBL259124"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL472193","canonicalSmiles":"O=C(Nc1cccc(C(F)(F)F)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1","inchiKey":"JJHXPDTVQKWKHA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL472193","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07360"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL488994","canonicalSmiles":"COc1c(O)c(OC)c2oc(-c3ccccc3O)cc(=O)c2c1O","inchiKey":"JWOKGWICZPPYPX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL488994","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13983"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL497318","canonicalSmiles":"CCCCCc1cc(O)c(C/C=C(\\C)CCC=C(C)C)c(O)c1","inchiKey":"QXACEHWTBCFNSA-SFQUDFHCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANNABIGEROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cannabigerol"],"crossReferences":{"Wikipedia":["Cannabigerol"],"drugbank":["DB14734"],"chEBI":["69477"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL500576","canonicalSmiles":"Oc1cccc(-c2c3nc(c(-c4cccc(O)c4)c4ccc([nH]4)c(-c4cccc(O)c4)c4nc(c(-c5cccc(O)c5)c5ccc2[nH]5)CC4)C=C3)c1","inchiKey":"LYPFDBRUNKHDGX-LWQDQPMZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL500576","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206512","144206848"],"drugbank":["DB11630"],"chEBI":["9437"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL501849","canonicalSmiles":"COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\\CCCCN(C)C(=O)[C@@H]4C3)cc(-c3nc(C(C)C)cs3)nc2c1C","inchiKey":"JTZZSQYMACOLNN-VDWJNHBNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMEPREVIR","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Olysio"],"synonyms":["Simeprevir","TMC 435","TMC 435350","TMC-435","TMC-435350","TMC435350"],"crossReferences":{"drugbank":["DB06290"]},"childChemblIds":["CHEMBL3137358"],"count":4,"approvedIndications":["EFO_0004220","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for chronic hepatitis c virus infection and viral disease and has 2 investigational indications."}
{"id":"CHEMBL502109","canonicalSmiles":"CCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1.[Cl-]","inchiKey":"XIWFQDBQMCDYJT-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"BENZALKONIUM CHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1187417","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Capitol","Dermax therapeutic","Drapolene","Roccal","Zephiran chloride"],"synonyms":["Benzalkonium chloride"],"crossReferences":{"PubChem":["26748812"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL504652","canonicalSmiles":"c1cncc(N2CCC3(CCCN3)C2)c1","inchiKey":"NXIPMBQVNTWEEX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TC-2216","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tc-2216"],"count":2,"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204"],"count":2},"linkedDiseases":{"rows":["MONDO_0002050","EFO_0005230"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL50588","canonicalSmiles":"CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21","inchiKey":"AUVVAXYIELKVAI-CKBKHPSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMETINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emetine","GNF-Pf-196","TCMDC-125531"],"crossReferences":{"PubChem":["144204452","170465705","29215025","50104287","50104288","90341404"],"Wikipedia":["Emetine"],"drugbank":["DB13393"],"chEBI":["4781"]},"childChemblIds":["CHEMBL493439","CHEMBL1255782","CHEMBL513000"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL512172","canonicalSmiles":"Cc1cc(C)cc(Nc2nccc(-c3nc(C)c(C(=O)N[C@@H](C)CO)s3)n2)c1","inchiKey":"PEGXADGTBNRSGV-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL512172","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07194"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL513922","canonicalSmiles":"CCN(Cc1ccccc1)C(=O)Cn1c(=O)n(C)c2cnc(-c3ccccc3)nc21","inchiKey":"NBMBIEOUVBHEBM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMAPUNIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AC-5216","Emapunil","XBD-173","XBD173"],"crossReferences":{"drugbank":["DB12666"]},"childChemblIds":["CHEMBL2206281"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL519260","canonicalSmiles":"CCNC(=O)/C=C(C)/C=C/C=C(C)/C=C/c1c(C)cc(OC)c(C)c1C","inchiKey":"IYIYMCASGKQOCZ-DJRRULDNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOTRETINIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Tasmaderm"],"synonyms":["Motretinide"],"crossReferences":{"drugbank":["DB13368"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL527","canonicalSmiles":"CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O","inchiKey":"QYSPLQLAKJAUJT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PIROXICAM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Brexidol","Feldene","Feldene 20","Feldene p","Flamatrol","Kentene","Larapam","Piroflam 10","Piroflam 20","Piroxicam","Pirozip 10","Pirozip 20"],"synonyms":["CP-16,171","CP-16171","NSC-666076","Piroxicam"],"crossReferences":{"DailyMed":["piroxicam"],"PubChem":["11111641","11111642","11113322","124881135","144203782","144207349","170464817","26746904","26751443","50085963","50103896","511550","856007","859011"],"Wikipedia":["Piroxicam"],"drugbank":["DB00554"],"chEBI":["8249"]},"childChemblIds":["CHEMBL2106953","CHEMBL1418195"],"count":9,"approvedIndications":["HP_0002829","HP_0003326","EFO_0000685","EFO_0002506","EFO_0005752","EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["HP_0002829","EFO_1001412","EFO_1001896","HP_0003326","EFO_0000685","EFO_0002506","EFO_0004616","HP_0100607","EFO_0005752","EFO_0005755","EFO_0000537"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 6 approved and 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL530","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](/N=C/N3CCCCCC3)C(=O)N2[C@H]1C(=O)O","inchiKey":"BWWVAEOLVKTZFQ-ISVUSNJMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMDINOCILLIN","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Coactin","Selexidin"],"synonyms":["Amdinocillin","FL 1060","FL-1060","Mecillinam","RO 10-9070","RO-10-9070"],"crossReferences":{"PubChem":["144205762","170465354"],"Wikipedia":["Mecillinam"]},"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984 and is indicated for bacterial disease."}
{"id":"CHEMBL53418","canonicalSmiles":"O=C1c2cccc(O)c2C(=O)c2c(O)cccc21","inchiKey":"QBPFLULOKWLNNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DANTHRON","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Carcinogenicity"]},"tradeNames":["Dorbane","Istizin"],"synonyms":["Chrysazin","Danthron","Dantron"],"crossReferences":{"PubChem":["144204673","144208184","170465532","17389963","26747347","73151","8139970"],"Wikipedia":["Dantron"],"drugbank":["DB04816"],"chEBI":["3682"]},"count":1,"approvedIndications":["HP_0002019"],"linkedTargets":{"rows":["ENSG00000186350"],"count":1},"linkedDiseases":{"rows":["HP_0002019"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for constipation. It was withdrawn in United States due to Carcinogenicity."}
{"id":"CHEMBL563327","canonicalSmiles":"CCNC(=O)c1cc2c(-c3cc(OCCN4CCCC4)c(Cl)cc3Cl)nc(N)nc2s1","inchiKey":"WJUNQSYQHHIVFX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL563327","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06969"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL58510","canonicalSmiles":"CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=P(O)(O)O.O=P(O)(O)O","inchiKey":"QKICWELGRMTQCR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROQUINE PHOSPHATE","yearOfFirstApproval":1949,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL76","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aralen","Avloclor","Chloroquine phosphate","Malarivon"],"synonyms":["Chloroquine Diphosphate","Chloroquine Phosphate","Chloroquine diphosphate","Chloroquine phosphate","NSC-14050","SN-7618","WR-1522"],"crossReferences":{"DailyMed":["chloroquine%20phosphate"],"PubChem":["144203666","144210036","170464753","26747477","26747478","50106055"]},"count":7,"approvedIndications":["EFO_0001068"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1949 and is indicated for malaria and has 6 investigational indications."}
{"id":"CHEMBL586701","canonicalSmiles":"Cc1ccc(C2Sc3ccccc3N=C3C2=C(O)c2ccccc23)cc1","inchiKey":"SFUWDBKYNKBXQU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZSTK-474","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GNF-PF-5468","ZSTK-474","Zstk-474"],"count":1,"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461"],"count":8},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL593830","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3F)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"NGTCPFGWXMBZEP-NQQHDEILSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL593830","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03488"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL598172","canonicalSmiles":"COc1ccc(NC(=O)Nc2ccc(F)cc2F)cc1-c1c(Br)cnn1C","inchiKey":"COSPVUFTLGQDQL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NELOTANSERIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APD-125","APD125","Apd-125","Nelotanserin"],"crossReferences":{"drugbank":["DB12555"]},"count":3,"linkedTargets":{"rows":["ENSG00000102468"],"count":1},"linkedDiseases":{"rows":["EFO_0006792","EFO_0004698","HP_0000738"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL65543","canonicalSmiles":"CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O","inchiKey":"CAHKINHBCWCHCF-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETYL TYROSINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetyl Tyrosine"],"crossReferences":{"PubChem":["170465742","29215325"],"drugbank":["DB11102"],"chEBI":["21563"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL83527","canonicalSmiles":"COc1cc(/C=C/c2ccc(O)cc2)cc(OC)c1","inchiKey":"VLEUZFDZJKSGMX-ONEGZZNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PTEROSTILBENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-(3,5-Dimethoxystyryl)Phenol","Pterostilben","Pterostilbene"],"crossReferences":{"PubChem":["26657958","26719768"],"Wikipedia":["Pterostilbene"],"chEBI":["8630"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL84446","canonicalSmiles":"NC(=O)[C@@H]1C[C@]2(NC(=O)NC2=O)c2cc(F)ccc2O1","inchiKey":"WAAPEIZFCHNLKK-UFBFGSQYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIDARESTAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fidarestat"],"crossReferences":{"PubChem":["144206034"],"drugbank":["DB02021"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL869","canonicalSmiles":"NC(=O)N/N=C/c1ccc([N+](=O)[O-])o1","inchiKey":"IAIWVQXQOWNYOU-FPYGCLRLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITROFURAZONE","yearOfFirstApproval":1945,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Actin-n","Furacin","Furacine","Furazone","Nitrofural","Nitrofurazone"],"synonyms":["Furacilin","NSC-1602","NSC-2100","Nitrofural","Nitrofurazone"],"crossReferences":{"PubChem":["144204548","144210186","144213996","170464946","17389801","26747226","26752739"],"TG-GATEs":["65"],"Wikipedia":["Nitrofural"],"drugbank":["DB00336"]},"childChemblIds":["CHEMBL1204113"],"count":4,"approvedIndications":["DOID_10113","EFO_0005044","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1945 and has 3 approved and 1 investigational indication. It was withdrawn in United States."}
{"id":"CHEMBL9417","canonicalSmiles":"N[C@@H](Cc1ccccc1)C(O)[C@@H](N)Cc1ccccc1","inchiKey":"GZBLEJZADHZBBZ-HOTGVXAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL9417","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07575"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL95","canonicalSmiles":"Nc1c2c(nc3ccccc13)CCCC2","inchiKey":"YLJREFDVOIBQDA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TACRINE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Tacrine"],"crossReferences":{"PubChem":["104171104","11110734","11113824","124879172","124879174","144203624","144212594","170465420","26755281","90341647"],"TG-GATEs":["60"],"Wikipedia":["Tacrine"],"drugbank":["DB00382"],"chEBI":["45980"]},"childChemblIds":["CHEMBL1677","CHEMBL1337960"],"count":2,"approvedIndications":["HP_0000726"],"linkedTargets":{"rows":["ENSG00000087085","ENSG00000114200"],"count":2},"linkedDiseases":{"rows":["EFO_0002610","HP_0000726"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for dementia and has 1 investigational indication."}
{"id":"CHEMBL95097","canonicalSmiles":"Cc1cc(Br)c(O)c(-c2nc3cc(C(=N)N)ccc3[nH]2)c1","inchiKey":"XKCHOMIJYLHXLI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL95097","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02288"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
